The 20% surge in attacks on Ukrainian healthcare isn't random; it's a calculated move targeting civilian morale and future capacity.
The push for ethical governance of AI in cardiovascular disease management hides a deeper power shift. Who truly benefits from algorithmic cardiology?
Smart nanotech targeting tumors is here, but the real story is the coming war for control over personalized cancer therapy access.
The appointment of a UFH scholar signals a seismic shift in South African **healthcare policy** and challenges the entrenched medical establishment.
AI scribes are flooding healthcare, but the real story isn't efficiency—it's data capture and physician burnout transfer. Analyze the hidden costs.
The shift from 'Dr. Google' to 'ChatGPT Health' isn't just an upgrade; it's a hostile takeover of medical self-diagnosis. Who truly profits?
Anthropic is pushing Claude into life sciences, but the real story isn't better diagnoses—it's who controls the new medical intelligence bottleneck.
Anthropic is pushing Claude into healthcare, but the real battle isn't clinical success; it’s controlling the future of proprietary medical data.
OpenAI’s ChatGPT Health launch is here. But beyond the hype, this move signals a massive power shift in medical AI, threatening independent practitioners.
Google's sudden halt on AI health summaries isn't about minor safety bugs; it's a calculated retreat from catastrophic legal exposure in the high-stakes world of digital health.
OpenAI's entry into healthcare isn't about better diagnoses; it's a calculated move to shift medical accountability. We analyze the real winners and losers in this AI power grab.
The British Heart Foundation's £10m data science push is great PR, but the real story in **cardiovascular research** funding is data ownership and privatization.